3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 1
2
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
3
Gynecologic
3
Breast
2
Thoracic
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Squamous Cell Carcinoma of Head and Neck
220
Head and Neck Neoplasms
172
Carcinoma, Non-Small-Cell Lung
104
Melanoma
63
Neoplasms
56
Colorectal Neoplasms
55
Uterine Cervical Neoplasms
53
Ovarian Neoplasms
50
Stomach Neoplasms
48
Neoplasm Metastasis
46
Breast Neoplasms
46
Triple Negative Breast Neoplasms
45
Lung Neoplasms
44
Carcinoma, Renal Cell
40
Esophageal Neoplasms
37
Nasopharyngeal Carcinoma
33
Endometrial Neoplasms
33
Pancreatic Neoplasms
32
Thyroid Neoplasms
30
Prostatic Neoplasms
26
Carcinoma, Squamous Cell
26
Sarcoma
25
Colonic Neoplasms
24
Urinary Bladder Neoplasms
23
Small Cell Lung Carcinoma
23
Oropharyngeal Neoplasms
23
Carcinoma, Transitional Cell
23
Carcinoma
22
Salivary Gland Neoplasms
20
Nasopharyngeal Neoplasms
20
Interventions
sargramostim
1
pembrolizumab
1
X-Rays
1
Specimen Handling
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Carcinosarcoma
×
Head & Neck
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled